Premenstrual Dysphoric DisorderPMDDNCT05327075
Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females
An observational study of Premenstrual Dysphoric Disorder, run by Al-Azhar University at 1 site in Egypt.
Trial summary
it is a cross-sectional study conducted in female patients attending outpatient clinc in our university hospital to assess their awareness regarding the symptoms of premenstrual dysphoric disorders. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Premenstrual Dysphoric Disorder
- What is being tested?
- questionnaire
- How many people
- 150 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Mar 2022to Dec 2022
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Adult
Study population: the study will include females attending gynecological clinics in two hospitals in delta region
Who may be able to join
- females in reproductive age
- history of regular menstruation
Who cannot join
- history of any psychological disorders
- history of chemotherapy in last 6 months
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females.Results of Surveying Two Centers in Delta Region
it is a cross-sectional study conducted in female patients attending outpatient clinc in our university hospital to assess their awareness regarding the symptoms of premenstrual dysphoric disorders.
Read the detailed description
this study will be conducted on females in the reproductive age attending the gynecological outpatient clinic to assess the prevalence of premenstrual dysphoric disorder(eeiPMDD) and their awareness regarding the symptoms of PMDD and the impact of these symptoms on their quality of life using questionnaire including ( knowledge , attitude and practice) of those Egyptian females.
- Conditions
- Premenstrual Dysphoric Disorder
- Being tested
- questionnaire
- Medical subject headings
- Premenstrual Dysphoric Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnaireOther
it is in the form of questionnaire and scoring tool
What is being measured
The primary outcome is the main question the study is designed to answer.
questionnaire " awareness of participants regarding PMDD symptoms"
knowledge , attitude and practice through the time of questionnaire
Measured: during the study, an avarege 1 month
Secondary outcomes (1)
questionnaire "impact of the PMDD symptoms on the participants life"
impact on their life questionnaire
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2022
- Study start15 Mar 2022
- Primary completionSep 2022 (estimated)
- Study completionDec 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Premenstrual Dysphoric DisorderStudies of the same condition, open and under way.
- More trials run by Al-Azhar UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 150 participants (estimated)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Al-Azhar University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Eman Ibrahim Abd Elrehim, Al-Azhar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05327075
- Sponsor's protocol ID
- IRB 00012367-22-03-001
- Acronym
- PMDD
- Status last verified
- Jul 2022
- First submitted
- 6 Apr 2022
- Last updated
- 21 Jul 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females.Results of Surveying Two Centers in Delta Region
- ClinicalTrials.gov ID
- NCT05327075
- Acronym / sponsor ID
- PMDD / IRB 00012367-22-03-001
- Conditions
- Premenstrual Dysphoric Disorder
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Al-Azhar UniversityUniversity, hospital or other
- Study start
- 15 Mar 2022 (actual)
- Primary completion
- Sep 2022 (estimated)
- Study completion
- Dec 2022 (estimated)
- First posted
- 14 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
it is a cross-sectional study conducted in female patients attending outpatient clinc in our university hospital to assess their awareness regarding the symptoms of premenstrual dysphoric disorders.
Detailed description
this study will be conducted on females in the reproductive age attending the gynecological outpatient clinic to assess the prevalence of premenstrual dysphoric disorder(eeiPMDD) and their awareness regarding the symptoms of PMDD and the impact of these symptoms on their quality of life using questionnaire including ( knowledge , attitude and practice) of those Egyptian females.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 30 Days
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- the study will include females attending gynecological clinics in two hospitals in delta region
Key inclusion criteria (2 listed)
- females in reproductive age
- history of regular menstruation
Key exclusion criteria (2 listed)
- history of any psychological disorders
- history of chemotherapy in last 6 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnaireit is in the form of questionnaire and scoring tool | Other | – |
Primary outcome
questionnaire " awareness of participants regarding PMDD symptoms"
Time frame: during the study, an avarege 1 month
knowledge , attitude and practice through the time of questionnaire
1 secondary outcome
questionnaire "impact of the PMDD symptoms on the participants life"
Time frame: 3 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Premenstrual Dysphoric Disorder
Not yet recruitingPhase 1
MLS101 Study in PMDD
Premenstrual Dysphoric Disorder ( PMDD), PMDD
Enrolling by invitation
Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Perimenopause, PMDD
RecruitingObservational study
Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health
Premenstrual Dysphoric Disorder (PMDD)
Not yet recruitingObservational study
The SPARK-PMDD Study
Premenstrual Dysphoric Disorder, PMDD
RecruitingObservational study
To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.
Premenstrual Dysphoric Disorder ( PMDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Premenstrual Dysphoric Disorder, run by Al-Azhar University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
questionnaire " awareness of participants regarding PMDD symptoms" (time frame: during the study, an avarege 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2022.